文献速递老年综合评估衰弱、肌少症与跌倒老年慢病共病管理

功能受损与表型衰弱与老年人特定医疗部门增量费用的关联

Functional Impairments, Phenotypic Frailty, and Sector-Specific Incremental Healthcare Costs in Older Adults.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2024-01-01

结果显示,功能受损与两性住院、SNF和HHC费用升高独立相关;表型衰弱与女性住院费用升高及两性SNF和HHC费用升高独立相关;两者均与门诊费用无关。

要点

  • 3-4项ADL受损者较无受损者,两性住院、SNF和HHC年化增量费用均升高。
  • 表型衰弱者较健壮者,女性住院费用升高,两性SNF和HHC费用升高。
  • 功能受损和表型衰弱均与门诊费用无独立关联。

核心结论

  • 在社区居住的医保受益人中,功能受损与两性后续住院、SNF和HHC部门费用升高独立相关。
  • 表型衰弱与女性后续住院费用升高独立相关,并与两性SNF和HHC费用升高独立相关。
  • 功能受损和表型衰弱均与门诊费用无关。

研究设计与样本

  • 索引检查时间为2002-2011年,平均年龄79.2岁,随访索引检查后36个月的费用。
  • 功能受损定义为4项日常生活活动(ADL)执行困难,衰弱表型用5个组分操作化。
  • 费用包括住院、专业护理机构(SNF)、家庭医疗(HHC)和门诊,以2023年美元计算年化值。
  • 分析中调整了基于理赔构建的加权多病指数(含人口学特征)及功能受损与衰弱表型彼此。

主要发现

  • 住院增量费用主要源于较高的住院风险,SNF和HHC增量费用与利用风险增加及利用者费用较高均有关。
  • 功能受损和表型衰弱均与门诊费用无关联。

关键数值与推荐

  • 功能受损定义为4项ADL执行困难,按3-4项受损与无受损比较。
  • 表型衰弱用5个组分操作化,按衰弱表型与健壮比较。
  • 费用部门包括住院、SNF、HHC和门诊,年化增量费用以2023年美元表示。

临床怎么用

  • 对社区老年人评估ADL受损和衰弱表型,有助于识别后续住院、SNF和HHC费用较高的高风险人群。
  • 功能受损和衰弱表型可作为老年综合评估中预测特定部门医疗资源使用的参考指标。
  • 针对功能受损和衰弱的干预可能有助于降低住院、SNF和HHC相关费用,但需结合临床判断。

局限性

  • 研究为观察性汇总分析,不能确立功能受损或衰弱与费用之间的因果关系。
  • 费用仅涵盖索引检查后36个月,且基于Medicare理赔,可能不适用于非医保人群。
  • 功能受损和衰弱表型基于队列数据定义,可能存在测量偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study quantifies incremental healthcare expenditures of functional impairments and phenotypic frailty in specific healthcare sectors. METHODS: Pooled 2023 analysis of 4 prospective cohort studies linked with Medicare claims including 4 318 women and 3 847 men attending an index examination (2002-2011). Annualized inpatient, skilled nursing facility (SNF), home healthcare (HHC), and outpatient costs (2023 dollars) ascertained for 36 months following index examination. Functional impairments (difficulty performing 4 activities of daily living) and frailty phenotype (operationalized using 5 components) derived from cohort data. Weighted multimorbidity index including demographics derived from claims. RESULTS: Mean age at index examination was 79.2 years. After accounting for multimorbidity and each other, average annualized incremental costs of 3-4 functional impairments versus no impairment in women (men) were $2 838 ($5 516) in inpatient, $1 572 ($1 446) in SNF, and $1 349 ($1 060) in HHC sectors; average incremental costs of phenotypic frailty versus robust in women (men) was $4 100 (not significant for men) in inpatient, $1 579 ($1 254) in SNF, and $645 ($526) in HHC sectors. Incremental inpatient costs were primarily due to a higher hospitalization risk, while incremental SNF and HHC costs were related to both increased risks of utilization and higher costs among individuals with utilization. Neither geriatric domain was associated with outpatient costs. CONCLUSIONS: In this study of community-dwelling beneficiaries, functional impairments were independently associated with higher subsequent expenditures in inpatient, SNF, and HHC sectors among both sexes. Phenotypic frailty was independently associated with higher subsequent inpatient costs in women, and higher SNF and HHC costs in both sexes.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Ensrud KE, Schousboe JT, Kats AM, et al. Functional Impairments, Phenotypic Frailty, and Sector-Specific Incremental Healthcare Costs in Older Adults. J Gerontol A Biol Sci Med Sci. 2024. PMID: 39383116. doi:10.1093/gerona/glae245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。